Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPS trial in acute coronary syndrome
ACTRN12615000861550Phase 3Completed
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Dec 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) and coronary arteriosclerosis comparing Colchicine plus standard medical therapy with Placebo plus standard medical therapy (2 arms). Primary endpoint: Major adverse cardiovascular events. Started Dec 2015; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12615000861550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000861550.